Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Reexamination Certificate
2008-04-08
2008-04-08
Henley, III, Raymond J. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
C514S653000, C514S826000
Reexamination Certificate
active
07354913
ABSTRACT:
Inhalable pharmaceutical compositions are provided, for use in the treatment of respiratory disorders such as asthma, rhinitis and chronic obstructive pulmonary disease (COPD). These compositions have high storage stability, and include formoterol and a corticosteroid.
REFERENCES:
patent: 5637620 (1997-06-01), Trofast et al.
patent: 5795564 (1998-08-01), Aberg et al.
patent: 5874063 (1999-02-01), Briggner et al.
patent: 6030604 (2000-02-01), Trofast
patent: 6869942 (2005-03-01), Trofast et al.
patent: 1 014 993 (2002-08-01), None
patent: 1 156 790 (2003-06-01), None
patent: 1 152 753 (2004-05-01), None
patent: WO 98/15280 (1998-04-01), None
patent: WO 9831351 (1998-07-01), None
patent: WO 99/15182 (1999-04-01), None
patent: WO 99/64014 (1999-12-01), None
patent: WO 00/28979 (2000-05-01), None
patent: WO 01/78693 (2001-10-01), None
patent: WO 01/78745 (2001-10-01), None
Remington's Pharmaceutical Sciences, published 1980 by Mack Publishing Company, 16thedition, pp. 431-435.
Comparative Data provided by Chiesi Farmaceutica S.p.A. during European Opposition proceedings (document D6 from opposition), 2 pages.
Zeng et al., “Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation,” International Journal of Pharmaceutics, 182 (1999), pp. 133-144.
Zeng et al., “Particulate Interactions in Dry Powder Formulations for Inhalation,” Taylor & Francis (2001), pp. 30, 31 and 159-161.
Malmqvist-Granlund Karin
Nilsson Per-Gunnar
Thalberg Kyrre
Trofast Eva
Astrazeneca AB
Fish & Richardson P.C.
Henley III Raymond J.
LandOfFree
High storage stability inhalable compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High storage stability inhalable compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High storage stability inhalable compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2776816